Genetics of alzheimer's disease

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Ridge, Perry G ^a   Ebbert, Mark T W ^a,b   Kauwe, John S K ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN; LIPID; MEMBRANE PROTEIN; MEMBRANE SPANNING 4 DOMAIN SUBFAMILY A MEMBER 4E; MEMBRANE SPANNING 4 DOMAIN SUBFAMILY A MEMBER 6A; PRESENILIN 1; PRESENILIN 2; UNCLASSIFIED DRUG;

ALLELE; ALZHEIMER DISEASE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 21; ENDOCYTOSIS; ENDOPHENOTYPE; EXON; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; GENOTYPE; HEREDITY; HOMEOSTASIS; HUMAN; MITOCHONDRIAL GENETICS; MITOCHONDRIAL GENOME; NUCLEOTIDE SEQUENCE; REVIEW; ANIMAL; GENETIC PREDISPOSITION; ONSET AGE;

AGE OF ONSET; ALZHEIMER DISEASE; ANIMALS; ENDOPHENOTYPES; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 84881539943     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/254954     Document Type: Review

References (194)

1. Querfurth H. W., LaFerla F. M., Alzheimer's disease. The New England Journal of Medicine 2010 362 4 329 344 2-s2.0-75449102536 10.1056/NEJMra0909142
2. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H. M., Forecasting the global burden of Alzheimer's disease. Alzheimer's and Dementia 2007 3 3 186 191 2-s2.0-34249697099 10.1016/j.jalz.2007.04.381 (Pubitemid 46825511)
3. Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E., Alzheimer's disease. The Lancet 2011 377 9770 1019 1031 2-s2.0-79952747862 10.1016/S0140-6736(10)61349-9
4. Dubois B., Feldman H. H., Jacova C., DeKosky S. T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P. J., Scheltens P., Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurology 2007 6 8 734 746 2-s2.0-34447322271 10.1016/S1474-4422(07)70178-3 (Pubitemid 47058377)
5. Hardy J. A., Higgins G. A., Alzheimer's disease: the amyloid cascade hypothesis. Science 1992 256 5054 184 185 2-s2.0-0026597063
6. Kim J., Onstead L., Randle S., Price R., Smithson L., Zwizinski C., Dickson D. W., Golde T., McGowan E., A β 40 inhibits amyloid deposition in vivo. The Journal of Neuroscience 2007 27 3 627 633 2-s2.0-33846435323 10.1523/JNEUROSCI.4849-06.2007 (Pubitemid 46143766)
7. Armstrong R. A., The pathogenesis of alzheimer's disease: a reevaluation of the 'amyloid cascade hypothesis'. International Journal of Alzheimer's Disease 2011 2011 6 2-s2.0-79953276681 10.4061/2011/630865 630865
8. Newell K. L., Hyman B. T., Growdon J. H., Hedley-Whyte E. T., Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. Journal of Neuropathology and Experimental Neurology 1999 58 11 1147 1155 2-s2.0-0032749171 (Pubitemid 29519838)
9. Ankarcrona M., Mangialasche F., Winblad B., Rethinking Alzheimer's disease therapy: are mitochondria the key? Journal of Alzheimer's Disease 2010 20 supplement 2 S579 S590 2-s2.0-77956219269 10.3233/JAD-2010-100327
10. Swerdlow R. H., Khan S. M., A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Medical Hypotheses 2004 63 1 8 20 2-s2.0-3042806534 10.1016/j.mehy.2003.12.045 (Pubitemid 38887104)
11. Mancuso M., Orsucci D., Siciliano G., Murri L., Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? Current Alzheimer Research 2008 5 5 457 468 2-s2.0-53549097920 10.2174/156720508785908946
12. Onyango I., Khan S., Miller B., Swerdlow R., Trimmer P., Bennett J. Jr., Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease. Journal of Alzheimer's Disease 2006 9 2 183 193 2-s2.0-33746048750 (Pubitemid 44078644)
13. Swerdlow R. H., Burns J. M., Khan S. M., The Alzheimer's disease mitochondrial cascade hypothesis. Journal of Alzheimer's Disease 2010 20 supplement 2 S265 S279 2-s2.0-77956224679 10.3233/JAD-2010-100339
14. Devi L., Prabhu B. M., Galati D. F., Avadhani N. G., Anandatheerthavarada H. K., Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. The Journal of Neuroscience 2006 26 35 9057 9068 2-s2.0-33748283747 10.1523/JNEUROSCI.1469-06.2006 (Pubitemid 44319397)
15. Anandatheerthavarada H. K., Devi L., Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease. Neuroscientist 2007 13 6 626 638 2-s2.0-35948969760 10.1177/1073858407303536 (Pubitemid 350077307)
16. Chan D. C., Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006 125 7 1241 1252 2-s2.0-33745274726 10.1016/j.cell.2006. 06.010 (Pubitemid 43929096)
17. Swerdlow R. H., Khan S. M., The Alzheimer's disease mitochondrial cascade hypothesis: an update. Experimental Neurology 2009 218 2 308 315 2-s2.0-67649687124 10.1016/j.expneurol.2009.01.011
18. Herrup K., Reimagining Alzheimer's disease-an age-based hypothesis. The Journal of Neuroscience 2010 30 50 16755 16762 2-s2.0-78650403081 10.1523/JNEUROSCI.4521-10.2010
19. Patterson C., Feightner J. W., Garcia A., Hsiung G.-Y. R., MacKnight C., Sadovnick A. D., Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. Canadian Medical Association Journal 2008 178 5 548 556 2-s2.0-40949105521 10.1503/cmaj.070796 (Pubitemid 351413998)
20. Cataldo J. K., Prochaska J. J., Glantz S. A., Cigarette smoking is a risk factor for Alzheimer's disease: an analysis controlling for tobacco industry affiliation. Journal of Alzheimer's Disease 2010 19 2 465 480 2-s2.0-77049104064 10.3233/JAD-2010-1240
21. Almeida O. P., Hulse G. K., Lawrence D., Flicker L., Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 2002 97 1 15 28 2-s2.0-0036140434 10.1046/j.1360-0443.2002.00016.x (Pubitemid 34038189)
22. Lindsay J., Laurin D., Verreault R., Hébert R., Helliwell B., Hill G. B., McDowell I., Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. American Journal of Epidemiology 2002 156 5 445 453 2-s2.0-0036725818 10.1093/aje/kwf074 (Pubitemid 34976983)
23. Podewils L. J., Guallar E., Kuller L. H., Fried L. P., Lopez O. L., Carlson M., Lyketsos C. G., Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. American Journal of Epidemiology 2005 161 7 639 651 2-s2.0-15744372044 10.1093/aje/kwi092 (Pubitemid 40411092)
24. Wang H.-X., Karp A., Winblad B., Fratiglioni L., Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen Project. American Journal of Epidemiology 2002 155 12 1081 1087 2-s2.0-0037097703 10.1093/aje/155.12.1081 (Pubitemid 34625496)
25. Scarmeas N., Stern Y., Mayeux R., Luchsinger J. A., Mediterranean diet, alzheimer disease, and vascular mediation. Archives of Neurology 2006 63 12 1709 1717 2-s2.0-33845533439 10.1001/archneur.63.12.noc60109 (Pubitemid 44925078)
26. Patterson C., Feightner J., Garcia A., MacKnight C., General risk factors for dementia: a systematic evidence review. Alzheimer's and Dementia 2007 3 4 341 347 2-s2.0-35148841086 10.1016/j.jalz.2007.07.001 (Pubitemid 47535136)
27. Blennow K., de Leon M. J., Zetterberg H., Alzheimer's disease. The Lancet 2006 368 9533 387 403 2-s2.0-33746310315 10.1016/S0140-6736(06)69113-7 (Pubitemid 44108123)
28. Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Hardy J., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991 349 6311 704 706 2-s2.0-0026088977 10.1038/349704a0 (Pubitemid 21912142)
29. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., St George-Hyslop P. H., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995 375 6534 754 760 2-s2.0-0029004341
30. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C.-E., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y.-H., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., Tanzi R. E., Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995 269 5226 973 977 2-s2.0-0029087026
31. Priller C., Bauer T., Mitteregger G., Krebs B., Kretzschmar H. A., Herms J., Synapse formation and function is modulated by the amyloid precursor protein. The Journal of Neuroscience 2006 26 27 7212 7221 2-s2.0-33746233383 10.1523/JNEUROSCI.1450-06.2006
32. Young-Pearse T. L., Bai J., Chang R., Zheng J. B., Loturco J. J., Selkoe D. J., A critical function for β -amyloid precursor protein in neuronal migration revealed by in utero RNA interference. The Journal of Neuroscience 2007 27 52 14459 14469 2-s2.0-37549040612 10.1523/JNEUROSCI.4701-07.2007
33. Thinakaran G., Koo E. H., Amyloid precursor protein trafficking, processing, and function. The Journal of Biological Chemistry 2008 283 44 29615 29619 2-s2.0-57649221135 10.1074/jbc.R800019200
34. Cruts M., Van Broeckhoven C., Molecular genetics of Alzheimer's disease. Annals of Medicine 1998 30 6 560 565 2-s2.0-0032408458 (Pubitemid 29012304)
35. Geller L. N., Potter H., Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. Neurobiology of Disease 1999 6 3 167 179 2-s2.0-0033033062 10.1006/nbdi.1999.0236 (Pubitemid 29297818)
36. Sleegers K., Brouwers N., Gijselinck I., Theuns J., Goossens D., Wauters J., Del-Favero J., Cruts M., Van Duijn C. M., Van Broeckhoven C., APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 2006 129 11 2977 2983 2-s2.0-33750579333 10.1093/brain/awl203 (Pubitemid 44684518)
37. Hooli B. V., Mohapatra G., Mattheisen M., Role of common and rare APP DNA sequence variants in Alzheimer disease. Neurology 2012 78 1250 1257
38. Janssen J. C., Beck J. A., Campbell T. A., Dickinson A., Fox N. C., Harvey R. J., Houlden H., Rossor M. N., Collinge J., Early onset familial Alzheimer's disease: mutation frequency in 31 families. Neurology 2003 60 2 235 239 2-s2.0-0037469171 (Pubitemid 36152015)
39. Raux G., Guyant-Maréchal L., Martin C., Bou J., Penet C., Brice A., Hannequin D., Frebourg T., Campion D., Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. Journal of Medical Genetics 2005 42 10 793 795 2-s2.0-26944475934 10.1136/jmg.2005.033456 (Pubitemid 41475257)
40. Rogaeva E., The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease. NeuroMolecular Medicine 2002 2 1 1 10 2-s2.0-0036364359 (Pubitemid 37012506)
41. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D. J., Mutation of the β -amyloid precursor protein in familial Alzheimer's disease increases β -protein production. Nature 1992 360 6405 672 674 2-s2.0-0026745610 10.1038/360672a0 (Pubitemid 23007680)
42. Citron M., Vigo-Pelfrey C., Teplow D. B., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L., Selkoe D. J., Excessive production of amyloid β -protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proceedings of the National Academy of Sciences of the United States of America 1994 91 25 11993 11997 2-s2.0-0028099612 10.1073/pnas.91.25.11993 (Pubitemid 24368590)
43. Haass C., Hung A. Y., Selkoe D. J., Teplow D. B., Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β -protein precursor. The Journal of Biological Chemistry 1994 269 26 17741 17748 2-s2.0-0028246308
44. Nilsberth C., Westlind-Danielsson A., Eckman C. B., Condron M. M., Axelman K., Forsell C., Stenh C., Luthman J., Teplow D. B., Younkin S. G., Näslund J., Lannfelt L., The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhanced A β protofibril formation. Nature Neuroscience 2001 4 9 887 893 2-s2.0-17944368176 10.1038/nn0901-887 (Pubitemid 32801591)
45. Haass C., Lemere C. A., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L., Selkoe D. J., The Swedish mutation causes early-onset Alzheimer's disease by β -secretase cleavage within the secretory pathway. Nature Medicine 1995 1 12 1291 1296 2-s2.0-0028866435
46. Dorpe J. V., Smeijers L., Dewachter I., Nuyens D., Spittaels K., Van den Haute C., Mercken M., Moechars D., Laenen I., Kuiperi C., Bruynseels K., Tesseur I., Loos R., Vanderstichele H., Checler F., Sciot R., Van Leuven F., Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. American Journal of Pathology 2000 157 4 1283 1298 2-s2.0-0033809909
47. Sahlin C., Lord A., Magnusson K., Englund H., Almeida C. G., Greengard P., Nyberg F., Gouras G. K., Lannfelt L., Nilsson L. N. G., The Arctic Alzheimer mutation favors intracellular amyloid- β production by making amyloid precursor protein less available to α -secretase. Journal of Neurochemistry 2007 101 3 854 862 2-s2.0-34247516510 10.1111/j.1471-4159.2006. 04443.x (Pubitemid 46646626)
48. Moechars D., Dewachter I., Lorent K., Reversé D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Van Den Haute C., Checler F., Godaux E., Cordell B., Van Leuven F., Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. The Journal of Biological Chemistry 1999 274 10 6483 6492 2-s2.0-0033525520 10.1074/jbc.274.10.6483 (Pubitemid 29111064)
49. Cruts M., van Duijn C. M., Backhovens H., Van Den Broeck M., Wehnert A., Serneels S., Sherrington R., Hutton M., Hardy J., St George-Hyslop P. H., Hofman A., Van Broeckhoven C., Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Human Molecular Genetics 1998 7 1 43 51 2-s2.0-6844255860 10.1093/hmg/7.1.43 (Pubitemid 28040736)
50. Campion D., Flaman J.-M., Brice A., Hannequin D., Dubois B., Martin C., Moreau V., Charbonnier F., Didierjean O., Tardieu S., Penet C., Puel M., Pasquier F., Le Doze F., Bellis G., Calenda A., Heilig R., Martinez M., Frebourg T., Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Human Molecular Genetics 1995 4 12 2373 2377 2-s2.0-0028812820
51. Hutton M., Busfield F., Wragg M., Crook R., Perez-Tur J., Clark R. F., Prihar G., Talbot C., Phillips H., Wright K., Baker M., Lendon C., Duff K., Martinez A., Houlden H., Nichols A., Karran E., Roberts G., Roques P., Rossor M., Craig Venter J., Adams M. D., Cline R. T., Phillips C. A., Fuldner R. A., Hardy J., Goate A., Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease. NeuroReport 1996 7 3 801 805 2-s2.0-9344237637 (Pubitemid 26146875)
52. Cruts M., Van Broeckhoven C., Presenilin mutations in Alzheimer's disease. Human Mutation 1998 11 183 190 (Pubitemid 28132873)
53. Jayadev S., Leverenz J. B., Steinbart E., Stahl J., Klunk W., Yu C.-E., Bird T. D., Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain 2010 133 4 1143 1154 2-s2.0-77950815769 10.1093/brain/awq033
54. Moehlmann T., Winkler E., Xia X., Edbauer D., Murrell J., Capell A., Kaether C., Zheng H., Ghetti B., Haass C., Steiner H., Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on A β 42 production. Proceedings of the National Academy of Sciences of the United States of America 2002 99 12 8025 8030 2-s2.0-18444391830 10.1073/pnas.112686799 (Pubitemid 34650999)
55. Rudzinski L. A., Fletcher R. M., Dickson D. W., Crook R., Hutton M. L., Adamson J., Graff-Radford N. R., Early onset familial alzheimer disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1. Alzheimer Disease and Associated Disorders 2008 22 3 299 307 2-s2.0-52649148210 10.1097/WAD.0b013e3181732399
56. Heckmann J. M., Low W.-C., de Villiers C., Rutherfoord S., Vorster A., Rao H., Morris C. M., Ramesar R. S., Kalaria R. N., Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease. Brain 2004 127 1 133 142 2-s2.0-0347989169 10.1093/brain/awh009 (Pubitemid 38055352)
57. Steiner H., Winkler E., Edbauer D., Prokop S., Basset G., Yamasaki A., Kostka M., Haass C., PEN-2 is an integral component of the γ -secretase complex required for coordinated expression of presenilin and nicastrin. The Journal of Biological Chemistry 2002 277 42 39062 39065 2-s2.0-0037131218 10.1074/jbc.C200469200 (Pubitemid 35190871)
58. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St. George Hyslop P., Selkoe D. J., Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β -protein in both transfected cells and transgenic mice. Nature Medicine 1997 3 1 67 72 2-s2.0-16944362157 10.1038/nm0197-67 (Pubitemid 27019143)
59. Schellenberg G. D., Bird T. D., Wijsman E. M., Orr H. T., Anderson L., Nemens E., White J. A., Bonnycastle L., Weber J. L., Alonso M. E., Potter H., Heston L. L., Martin G. M., Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992 258 5082 668 671 2-s2.0-0026471656
60. Ryan N. S., Rossor M. N., Correlating familial Alzheimers disease gene mutations with clinical phenotype. Biomarkers in Medicine 2010 4 1 99 112 2-s2.0-77951694945 10.2217/bmm.09.92
61. Sherrington R., Froelich S., Sorbi S., Campion D., Chi H., Rogaeva E. A., Levesque G., Rogaev E. I., Lin C., Liang Y., Ikeda M., Mar L., Brice A., Agid Y., Percy M. E., Clerget-Darpoux F., Piacentini S., Marcon G., Nacmias B., Amaducci L., Frebourg T., Lannfelt L., Rommens J. M., St George-Hyslop P. H., Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Human Molecular Genetics 1996 5 7 985 988 2-s2.0-8944241774 10.1093/hmg/5.7.985 (Pubitemid 26232280)
62. Kovacs D. M., Fausett H. J., Page K. J., Kim T.-W., Moir R. D., Merriam D. E., Hollister R. D., Hallmark' O. G., Mancini R., Felsenstein K. M., Hyman B. T., Tanzi R. E., Wasco W., Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Medicine 1996 2 2 224 229 2-s2.0-13344282063 10.1038/nm0296-224 (Pubitemid 26057557)
63. Bertram L., McQueen M. B., Mullin K., Blacker D., Tanzi R. E., Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genetics 2007 39 1 17 23 2-s2.0-33845892752 10.1038/ng1934 (Pubitemid 46026496)
64. Mahley R. W., Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988 240 4852 622 630 2-s2.0-0024299370
65. Eisenberg D. T. A., Kuzawa C. W., Hayes M. G., Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. American Journal of Physical Anthropology 2010 143 1 100 111 2-s2.0-77956130453 10.1002/ajpa.21298
66. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993 261 5123 921 923 2-s2.0-0027194791 (Pubitemid 23275809)
67. Hendrie H. C., Hall K. S., Hui S., Unverzagt F. W., Yu C. E., Lahiri D. K., Sahota A., Farlow M., Musick B., Class C. A., Brashear A., Burdine V. E., Osuntokun B. O., Ogunniyi A. O., Gureje O., Baiyewu O., Schellenberg G. D., Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Annals of Neurology 1995 37 1 118 120 2-s2.0-0028961402 10.1002/ana.410370123
68. Maestre G., Ottman R., Stern Y., Gurland B., Chun M., Tang M.-X., Shelanski M., Tycko B., Mayeux R., Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Annals of Neurology 1995 37 2 254 259 2-s2.0-0028816355 10.1002/ana.410370217
69. Noguchi S., Murakami K., Yamada N., Payami H., Kaye J., Heston L. L., Bird T. D., Schellenberg G. D., Apolipoprotein E genotype and Alzheimer's disease. The Lancet 1993 342 8873 737 738 2-s2.0-0027203749 10.1016/0140- 6736(93)91728-5 (Pubitemid 23279771)
70. Ueki A., Kawano M., Namba Y., Kawakami M., Ikeda K., A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neuroscience Letters 1993 163 2 166 168 2-s2.0-0027146623 10.1016/0304-3940(93)90373-S (Pubitemid 24005407)
71. Harold D., Abraham R., Hollingworth P., Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics 2009 41 1088 1093
72. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C. Jr., Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A., Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics 1994 7 2 180 184 2-s2.0-0028305380 10.1038/ng0694-180 (Pubitemid 24174658)
73. Reiman E. M., Chen K., Liu X., Bandy D., Yu M., Lee W., Ayutyanont N., Keppler J., Reeder S. A., Langbaum J. B. S., Alexander G. E., Klunk W. E., Mathis C. A., Price J. C., Aizensteini H. J., DeKosky S. T., Caselli R. J., Fibrillar amyloid- β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2009 106 16 6820 6825 2-s2.0-66149084048 10.1073/pnas.0900345106
74. Bales K. R., Dodart J. C., DeMattos R. B., Holtzman D. M., Paul S. M., Apolipoprotein E, amyloid, and Alzheimer disease. Molecular Interventions 2002 2 6 363 375 2-s2.0-0345072821
75. Koistinaho M., Lin S., Wu X., Esterman M., Koger D., Hanson J., Higgs R., Liu F., Malkani S., Bales K. R., Paul S. M., Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid- β peptides. Nature Medicine 2004 10 7 719 726 2-s2.0-3142781310 10.1038/nm1058 (Pubitemid 38937637)
76. Jiang Q., Lee C. Y. D., Mandrekar S., Wilkinson B., Cramer P., Zelcer N., Mann K., Lamb B., Willson T. M., Collins J. L., Richardson J. C., Smith J. D., Comery T. A., Riddell D., Holtzman D. M., Tontonoz P., Landreth G. E., ApoE promotes the proteolytic degradation of A β Neuron 2008 58 5 681 693 2-s2.0-44649197748 10.1016/j.neuron.2008.04.010 (Pubitemid 351778466)
77. Biffi A., Anderson C. D., Desikan R. S., Sabuncu M., Cortellini L., Schmansky N., Salat D., Rosand J., Genetic variation and neuroimaging measures in Alzheimer disease. Archives of Neurology 2010 67 6 677 685 2-s2.0-77953625064 10.1001/archneurol.2010.108
78. Carrasquillo M. M., Belbin O., Hunter T. A., Ma L., Bisceglio G. D., Zou F., Crook J. E., Pankratz V. S., Dickson D. W., Graff-Radford N. R., Petersen R. C., Morgan K., Younkin S. G., Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Archives of Neurology 2010 67 8 961 964 2-s2.0-77955463899 10.1001/archneurol.2010.147
79. Corneveaux J. J., Myers A. J., Allen A. N., Pruzin J. J., Ramirez M., Engel A., Nalls M. A., Chen K., Lee W., Chewning K., Villa S. E., Meechoovet H. B., Gerber J. D., Frost D., Benson H. L., O'Reilly S., Chibnik L. B., Shulman J. M., Singleton A. B., Craig D. W., Van Keuren-Jensen K. R., Dunckley T., Bennett D. A., de Jager P. L., Heward C., Hardy J., Reiman E. M., Huentelman M. J., Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Human Molecular Genetics 2010 19 16 3295 3301 2-s2.0-77955036445 10.1093/hmg/ddq221 ddq221
80. Giedraitis V., Kilander L., Degerman-Gunnarsson M., Sundelöf J., Axelsson T., Syvänen A.-C., Lannfelt L., Glaser A., Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men. Dementia and Geriatric Cognitive Disorders 2009 27 1 59 68 2-s2.0-58149340833 10.1159/000191203
81. Guerreiro R. J., Beck J., Gibbs J. R., Santana I., Rossor M. N., Schott J. M., Nalls M. A., Ribeiro H., Santiago B., Fox N. C., Oliveira C., Collinge J., Mead S., Singleton A., Hardy J., Genetic variability in CLU and its association with Alzheimer's disease. PLoS ONE 2010 5 3 2-s2.0-77949784437 10.1371/journal.pone.0009510 e9510
82. Hu X., Pickering E., Liu Y. C., Hall S., Fournier H., Katz E., Dechairo B., John S., van Eerdewegh P., Soares H., Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease. PLoS ONE 2011 6 2 2-s2.0-79952089521 10.1371/journal.pone.0016616 e16616
83. Jun G., Naj A. C., Beecham G. W., Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of Neurology 2010 67 1473 1484
84. Kamboh M. I., Minster R. L., Demirci F. Y., Ganguli M., DeKosky S. T., Lopez O. L., Barmada M. M., Association of CLU and PICALM variants with Alzheimer's disease. Neurobiology of Aging 2012 33 3 518 521 2-s2.0-84855801442 10.1016/j.neurobiolaging.2010.04.015
85. Lambert J.-C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M. J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., De Pancorbo M. M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Boss P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanché H., Dartigues J.-F., Tzourio C., Gut I., Van Broeckhoven C., Alpérovitch A., Lathrop M., Amouyel P., Arosio B., Coto E., Zompo M. D., Deramecourt V., Epelbaum J., Forti P., Brice A., Ferri R., Scarpini E., Siciliano G., Solfrizzi V., Sorbi S., Spalletta G., Ravaglia G., Sahel J., Valdivieso F., Vepsäläinen S., Pilotto A., Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics 2009 41 10 1094 1099 2-s2.0-78549264026 10.1038/ng.439
86. Naj A. C., Jun G., Beecham G. W., Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics 2011 43 436 441
87. Seshadri S., Fitzpatrick A. L., Ikram M. A., Genome-wide analysis of genetic loci associated with Alzheimer disease. Journal of the American Medical Association 2010 303 18 1832 1840 2-s2.0-77958116437 10.1001/jama.2010.1173
88. Tycko B., Feng L., Nguyen L., Polymorphisms in the human apolipoprotein-J/clusterin gene: ethnic variation and distribution in Alzheimer's disease. Human Genetics 1996 98 430 436 (Pubitemid 26336167)
89. Yu J.-T., Li L., Zhu Q.-X., Zhang Q., Zhang W., Wu Z.-C., Guan J., Tan L., Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease. Clinica Chimica Acta 2010 411 19-20 1516 1519 2-s2.0-77955049825 10.1016/j.cca.2010.06.013
90. Wijsman E. M., Pankratz N. D., Choi Y., Rothstein J. H., Faber K. M., Cheng R., Lee J. H., Bird T. D., Bennett D. A., Diaz-Arrastia R., Goate A. M., Farlow M., Ghetti B., Sweet R. A., Foroud T. M., Mayeux R., Genome-wide association of familial late-onset alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genetics 2011 7 2 2-s2.0-79952256613 10.1371/journal.pgen.1001308 e1001308
91. Elias-Sonnenschein L. S., Helisalmi S., Natunen T., Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort. PLoS One 2013 8 e59676
92. DeMattos R. B., O'dell M. A., Parsadanian M., Taylor J. W., Harmony J. A. K., Bales K. R., Paul S. M., Aronow B. J., Holtzman D. M., Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2002 99 16 10843 10848 2-s2.0-0036678856 10.1073/pnas.162228299
93. DeMattos R. B., Cirrito J. R., Parsadanian M., May P. C., O'Dell M. A., Taylor J. W., Harmony J. A. K., Aronow B. J., Bales K. R., Paul S. M., Holtzman D. M., ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 2004 41 2 193 202 2-s2.0-9144224765 10.1016/S0896-6273(03)00850-X (Pubitemid 38125181)
94. Bell R. D., Sagare A. P., Friedman A. E., Bedi G. S., Holtzman D. M., Deane R., Zlokovic B. V., Transport pathways for clearance of human Alzheimer's amyloid β -peptide and apolipoproteins E and J in the mouse central nervous system. Journal of Cerebral Blood Flow and Metabolism 2007 27 5 909 918 2-s2.0-34247506244 10.1038/sj.jcbfm.9600419 (Pubitemid 46659038)
95. Schrijvers E. M. C., Koudstaal P. J., Hofman A., Breteler M. M. B., Plasma clusterin and the risk of Alzheimer disease. Journal of the American Medical Association 2011 305 13 1322 1326 2-s2.0-79953747266 10.1001/jama.2011.381
96. Thambisetty M., An Y., Kinsey A., Koka D., Saleem M., Guntert A., Kraut M., Ferrucci L., Davatzikos C., Lovestone S., Resnick S. M., Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. NeuroImage 2012 59 1 212 217 2-s2.0-80054107095 10.1016/j. neuroimage.2011.07.056
97. Thambisetty M., Simmons A., Velayudhan L., Hye A., Campbell J., Zhang Y., Wahlund L.-O., Westman E., Kinsey A., Güntert A., Proitsi P., Powell J., Causevic M., Killick R., Lunnon K., Lynham S., Broadstock M., Choudhry F., Howlett D. R., Williams R. J., Sharp S. I., Mitchelmore C., Tunnard C., Leung R., Foy C., O'Brien D., Breen G., Furney S. J., Ward M., Kloszewska I., Mecocci P., Soininen H., Tsolaki M., Vellas B., Hodges A., Murphy D. G. M., Parkins S., Richardson J. C., Resnick S. M., Ferrucci L., Wong D. F., Zhou Y., Muehlboeck S., Evans A., Francis P. T., Spenger C., Lovestone S., Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Archives of General Psychiatry 2010 67 7 739 748 2-s2.0-77954510398 10.1001/archgenpsychiatry.2010.78
98. Ladu M. J., Shah J. A., Reardon C. A., Getz G. S., Bu G., Hu J., Guo L., Van Eldik L. J., Apolipoprotein E receptors mediate the effects of β -amyloid on astrocyte cultures. The Journal of Biological Chemistry 2000 275 43 33974 33980 2-s2.0-0034721849 10.1074/jbc.M000602200
99. Trougakos I. P., Gonos E. S., Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radical Research 2006 40 12 1324 1334 2-s2.0-33750694197 10.1080/10715760600902310 (Pubitemid 44698281)
100. Zlokovic B. V., Martel C. L., Matsubara E., Mccomb J. G., Zheng G., Mccluskey R. T., Frangione B., Ghiso J., Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid β at the blood-brain and blood-cerebrospinal fluid barriers. Proceedings of the National Academy of Sciences of the United States of America 1996 93 9 4229 4234 2-s2.0-0029920929
101. Matsubara E., Soto C., Governale S., Frangione B., Ghiso J., Apolipoprotein J and Alzheimer's amyloid β solubility. Biochemical Journal 1996 316 2 671 679 2-s2.0-0030014990
102. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.-C., Carrasquillo M. M., Abraham R., Hamshere M. L., Pahwa J. S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M. K., Brayne C., Rubinsztein D. C., Gill M., Lawlor B., Lynch A., Brown K. S., Passmore P. A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A. D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P. G., Hooper N. M., Vardy E. R. L. C., Hardy J., Mead S., Fox N. C., Rossor M., Collinge J., Maier W., Jessen F., Rüther E., Schürmann B., Heun R., Kölsch H., Van Den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Gallacher J., Hüll M., Rujescu D., Giegling I., Goate A. M., Kauwe J. S. K., Cruchaga C., Nowotny P., Morris J. C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P. P., Van Broeckhoven C., Livingston G., Bass N. J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C. E., Tsolaki M., Singleton A. B., Guerreiro R., Mühleisen T. W., Nöthen M. M., Moebus S., Jöckel K.-H., Klopp N., Wichmann H.-E., Pankratz V. S., Sando S. B., Aasly J. O., Barcikowska M., Wszolek Z. K., Dickson D. W., Graff-Radford N. R., Petersen R. C., Van Duijn C. M., Breteler M. M. B., Ikram M. A., Destefano A. L., Fitzpatrick A. L., Lopez O., Launer L. J., Seshadri S., Berr C., Campion D., Epelbaum J., Dartigues J.-F., Tzourio C., Alpérovitch A., Lathrop M., Feulner T. M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., SnÆdal J., Björnsson S., Jonsson P. V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M. J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., Alvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossù P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P. A., Jonsson T., Riemenschneider M., Morgan K., Younkin S. G., Owen M. J., O'Donovan M., Amouyel P., Williams J., Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics 2011 43 5 429 435 2-s2.0-79955484414 10.1038/ng.803
103. Tanaka N., Abe-Dohmae S., Iwamoto N., Fitzgerald M. L., Yokoyama S., Helical apolipoproteins of high-density lipoprotein enhance phagocytosis by stabilizing ATP-binding cassette transporter A7. Journal of Lipid Research 2010 51 9 2591 2599 2-s2.0-77956826011 10.1194/jlr.M006049
104. Hayashi M., Abe-Dohmae S., Okazaki M., Ueda K., Yokoyama S., Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. Journal of Lipid Research 2005 46 8 1703 1711 2-s2.0-23244437748 10.1194/jlr.M500092- JLR200 (Pubitemid 41099337)
105. Tanaka N., Abe-Dohmae S., Iwamoto N., Yokoyama S., Roles of ATP-binding cassette transporter A7 in cholesterol homeostasis and host defense system. Journal of Atherosclerosis and Thrombosis 2011 18 4 274 281 2-s2.0-80053626711 10.5551/jat.6726
106. Kaminski W. E., Orsó E., Diederich W., Klucken J., Drobnik W., Schmitz G., Identification of a novel human sterol-sensitive ATP-binding cassette transporter (ABCA7). Biochemical and Biophysical Research Communications 2000 273 2 532 538 2-s2.0-0033890964 10.1006/bbrc.2000.2954 (Pubitemid 30599020)
107. Bales K. R., Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Neuropharmacology 2010 59 4-5 295 302 2-s2.0-77955921493 10.1016/j.neuropharm.2010.01.005
108. Di Paolo G., Kim T.-W., Linking lipids to Alzheimer's disease: cholesterol and beyond. Nature Reviews Neuroscience 2011 12 5 284 296 2-s2.0-79955051063 10.1038/nrn3012
109. Matsuzaki T., Sasaki K., Hata J., Hirakawa Y., Fujimi K., Ninomiya T., Suzuki S. O., Kanba S., Kiyohara Y., Iwaki T., Association of Alzheimer disease pathology with abnormal lipid metabolism: the hisayama study. Neurology 2011 77 11 1068 1075 2-s2.0-80155141526 10.1212/WNL.0b013e31822e145d
110. Wu F., Yao P. J., Clathrin-mediated endocytosis and Alzheimer's disease: an update. Ageing Research Reviews 2009 8 3 147 149 2-s2.0-67349129779 10.1016/j.arr.2009.03.002
111. Lee J. H., Cheng R., Barral S., Reitz C., Medrano M., Lantigua R., Jiménez-Velazquez I. Z., Rogaeva E., St. George-Hyslop P. H., Mayeux R., Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Archives of Neurology 2011 68 3 320 328 2-s2.0-79952592605 10.1001/archneurol.2010.292
112. Cousin M. A., Robinson P. J., The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis. Trends in Neurosciences 2001 24 11 659 665 2-s2.0-0035510916 10.1016/S0166-2236(00)01930-5 (Pubitemid 33152773)
113. Simpson F., Hussain N. K., Qualmann B., Kelly R. B., Brian K K., McPherson P. S., Schmid S. L., SH3-domain-containing proteins function at distinct steps in clathrin-coated vesicle formation. Nature Cell Biology 1999 1 2 119 124 2-s2.0-0033147449 (Pubitemid 129501954)
114. Reiman E. M., Webster J. A., Myers A. J., Hardy J., Dunckley T., Zismann V. L., Joshipura K. D., Pearson J. V., Hu-Lince D., Huentelman M., Craig D. W., Coon K. D., Liang W. S., Herbert R. H., Beach T., Rohrer K. C., Zhao A. S., Leung D., Bryden L., Marlowe L., Kaleem M., Mastroeni D., Grover A., Heward C. B., Ravid R., Rogers J., Hutton M. L., Melquist S., Petersen R. C., Alexander G. E., Caselli R., Kukull W., Papassotiropoulos A., Stephan D. A., GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007 54 5 713 720 2-s2.0-34249745769 10.1016/j.neuron.2007.05.022 (Pubitemid 46843528)
115. Harel A., Mattson M. P., Yao P. J., CALM, a clathrin assembly protein, influences cell surface GluR2 abundance. NeuroMolecular Medicine 2011 13 1 88 90 2-s2.0-79952697049 10.1007/s12017-010-8142-6
116. Harel A., Wu F., Mattson M. P., Morris C. M., Yao P. J., Evidence for CALM in directing VAMP2 trafficking. Traffic 2008 9 3 417 429 2-s2.0-38849199843 10.1111/j.1600-0854.2007.00694.x (Pubitemid 351189000)
117. Dreyling M. H., Martinez-Climent J. A., Zheng M., Mao J., Rowley J. D., Bohlander S. K., The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proceedings of the National Academy of Sciences of the United States of America 1996 93 10 4804 4809 2-s2.0-0029953937 10.1073/pnas.93.10.4804 (Pubitemid 26162832)
118. Zhang Q., Yu J.-T., Zhu Q.-X., Zhang W., Wu Z.-C., Miao D., Tan L., Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease. Brain Research 2010 1348 216 221 2-s2.0-77955709299 10.1016/j.brainres.2010.06. 018
119. Rogers J., Li R., Mastroeni D., Grover A., Leonard B., Ahern G., Cao P., Kolody H., Vedders L., Kolb W. P., Sabbagh M., Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes. Neurobiology of Aging 2006 27 12 1733 1739 2-s2.0-33750031006 10.1016/j.neurobiolaging.2005.09.043 (Pubitemid 44572574)
120. Arumugam T. V., Magnus T., Woodruff T. M., Proctor L. M., Shiels I. A., Taylor S. M., Complement mediators in ischemia-reperfusion injury. Clinica Chimica Acta 2006 374 1-2 33 45 2-s2.0-33750028305 10.1016/j.cca.2006.06.010 (Pubitemid 44572249)
121. Yaddanapudi S., Altintas M. M., Kistler A. D., CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. The Journal of Clinical Investigation 2011 121 3965 3980
122. Ma Y., Yang H., Qi J., Liu D., Xiong P., Xu Y., Feng W., Zheng G., Li P., Fang M., Tan Z., Zheng F., Gong F., CD2AP is indispensable to multistep cytotoxic process by NK cells. Molecular Immunology 2010 47 5 1074 1082 2-s2.0-74449083582 10.1016/j.molimm.2009.11.004
123. Kobayashi S., Sawano A., Nojima Y., Shibuya M., Maru Y., The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1). The FASEB Journal 2004 18 7 929 931 2-s2.0-4644302353
124. Ishibashi K., Suzuki M., Sasaki S., Imai M., Identification of a new multigene four-transmembrane family (MS4A) related to CD20, HTm4 and β subunit of the high-affinity IgE receptor. Gene 2001 264 1 87 93 2-s2.0-0035819546 10.1016/S0378-1119(00)00598-9 (Pubitemid 32195491)
125. Liang Y., Buckley T. R., Tu L., Langdon S. D., Tedder T. F., Structural organization of the human MS4A gene cluster on Chromosome 11q12. Immunogenetics 2001 53 5 357 368 2-s2.0-0034881203 10.1007/s002510100339 (Pubitemid 32762813)
126. Bertram L., Lange C., Mullin K., Parkinson M., Hsiao M., Hogan M. F., Schjeide B. M. M., Hooli B., DiVito J., Ionita I., Jiang H., Laird N., Moscarillo T., Ohlsen K. L., Elliott K., Wang X., Hu-Lince D., Ryder M., Murphy A., Wagner S. L., Blacker D., Becker K. D., Tanzi R. E., Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. American Journal of Human Genetics 2008 83 5 623 632 2-s2.0-55049142500 10.1016/j.ajhg.2008.10.008
127. Bettens K., Brouwers N., Van Miegroet H., Gil A., Engelborghs S., De Deyn P. P., Vandenberghe R., Van Broeckhoven C., Sleegers K., Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association. Journal of Alzheimer's Disease 2010 19 4 1169 1175 2-s2.0-77950348446 10.3233/JAD-2010-1310
128. Brinkman-Van der Linden E. C. M., Angata T., Reynolds S. A., Powell L. D., Hedrick S. M., Varki A., CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Molecular and Cellular Biology 2003 23 12 4199 4206 2-s2.0-0038656361 10.1128/MCB.23.12.4199-4206.2003 (Pubitemid 36666423)
129. Jonsson T., Atwal J. K., Steinberg S., A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012 488 96 99
130. Guerreiro R., Wojtas A., Bras J., TREM2 variants in Alzheimer's disease. The New England Journal of Medicine 2013 368 117 127
131. Jonsson T., Stefansson H., Steinberg S., Variant of TREM2 associated with the risk of Alzheimer's disease. The New England Journal of Medicine 2013 368 107 116
132. Takasaki S., Mitochondrial haplogroups associated with Japanese Alzheimer's patients. Journal of Bioenergetics and Biomembranes 2009 41 5 407 410 2-s2.0-70449435784 10.1007/s10863-009-9240-8
133. Maruszak A., Canter J. A., Styczyńska M., Zekanowski C., Barcikowska M., Mitochondrial haplogroup H and Alzheimer's disease-is there a connection? Neurobiology of Aging 2009 30 11 1749 1755 2-s2.0-70049112960 10.1016/j.neurobiolaging.2008.01.004
134. Fesahat F., Houshmand M., Panahi M. S. S., Gharagozli K., Mirzajani F., Do haplogroups H and U act to increase the penetrance of Alzheimer's disease? Cellular and Molecular Neurobiology 2007 27 3 329 334 2-s2.0-34248597788 10.1007/s10571-006-9126-9 (Pubitemid 46763880)
135. Santoro A., Balbi V., Balducci E., Pirazzini C., Rosini F., Tavano F., Achilli A., Siviero P., Minicuci N., Bellavista E., Mishto M., Salvioli S., Marchegiani F., Cardelli M., Olivieri F., Nacmias B., Chiamenti A. M., Benussi L., Ghidoni R., Rose G., Gabelli C., Binetti G., Sorbi S., Crepaldi G., Passarino G., Torroni A., Franceschi C., Evidence for sub-haplogroup H5 of mitochondrial DNA as a risk factor for late onset alzheimer's disease. PLoS ONE 2010 5 8 2-s2.0-77957822416 10.1371/journal.pone.0012037 e12037
136. Ridge P., Maxwell T., Corcoran C., Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroups H6A1A/H6A1B: the Cache County Study on Memory in Aging. PLoS One 2012 7 e45134
137. Carrieri G., Bonafè M., De Luca M., Rose G., Varcasia O., Bruni A., Maletta R., Nacmias B., Sorbi S., Corsonello F., Feraco E., Andreev K. F., Yashin A. I., Franceschi C., De Benedictis G., Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Human Genetics 2001 108 3 194 198 2-s2.0-17744397107 10.1007/s004390100463 (Pubitemid 32293664)
138. van der Walt J. M., Dementieva Y. A., Martin E. R., Scott W. K., Nicodemus K. K., Kroner C. C., Welsh-Bohmer K. A., Saunders A. M., Roses A. D., Small G. W., Schmechel D. E., Murali Doraiswamy P., Gilbert J. R., Haines J. L., Vance J. M., Pericak-Vance M. A., Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neuroscience Letters 2004 365 1 28 32 2-s2.0-3242707016 10.1016/j.neulet.2004.04.051 (Pubitemid 38952729)
139. Lakatos A., Derbeneva O., Younes D., Keator D., Bakken T., Lvova M., Brandon M., Guffanti G., Reglodi D., Saykin A., Weiner M., Macciardi F., Schork N., Wallace D. C., Potkin S. G., Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiology of Aging 2010 31 8 1355 1363 2-s2.0-77954034861 10.1016/j.neurobiolaging.2010.04.031
140. Zsurka G., Kálmán J., Juhász A., Császár A., Raskó I., Janka Z., Venetianer P., No mitochondrial haplotype was found to increase risk for Alzheimer's disease. Biological Psychiatry 1998 44 5 371 373 2-s2.0-0344625398 10.1016/S0006-3223(97) 00461-7 (Pubitemid 28445518)
141. Chinnery P. F., Taylor G. A., Howell N., Andrews R. M., Morris C. M., Taylor R. W., McKeith I. G., Perry R. H., Edwardson J. A., Turnbull D. M., Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology 2000 55 2 302 304 2-s2.0-0033852515 (Pubitemid 30604638)
142. Pyle A., Foltynie T., Tiangyou W., Lambert C., Keers S. M., Allcock L. M., Davison J., Lewis S. J., Perry R. H., Barker R., Burn D. J., Chinnery P. F., Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Annals of Neurology 2005 57 4 564 567 2-s2.0-20144389920 10.1002/ana.20417 (Pubitemid 40471169)
143. Mancuso M., Nardini M., Micheli D., Rocchi A., Nesti C., Giglioli N. J., Petrozzi L., Rossi C., Ceravolo R., Bacci A., Choub A., Ricci G., Tognoni G., Manca M. L., Siciliano G., Murri L., Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany. Neurological Sciences 2007 28 3 142 147 2-s2.0-34447265267 10.1007/s10072-007-0807-z (Pubitemid 47039841)
144. Krüger J., Hinttala R., Majamaa K., Remes A. M., Mitochondrial DNA haplogroups in early-onset Alzheimer's disease and frontotemporal lobar degeneration. Molecular Neurodegeneration 2010 5, article 8 2-s2.0-77749329938 10.1186/1750-1326-5-8
145. Hudson G., Sims R., Harold D., No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology 2012 78 14 1038 1042
146. Schott J. M., ADNI Investigators, Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. Neurobiology of Aging 2011 33 7 1486.e9 1486.e15 2-s2.0-79953189065 10.1016/j.neurobiolaging.2011.02.008
147. Peterson D., Munger C., Crowley J., Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study. Alzheimer's & Dementia 2013 10.1016/j.jalz.2013.02.010
148. Cruchaga C., Kauwe J. S., Harari O., GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron 2013 78 256 268
149. Cruchaga C., Kauwe J. S. K., Mayo K., Spiegel N., Cruchaga C., Kauwe J. S. K., Mayo K., Spiegel N., Bertelsen S., Nowotny P., Shah A. R., Abraham R., Hollingworth P., Harold D., Owen M. M., Williams J., Lovestone S., Peskind E. R., Li G., Leverenz J. B., Galasko D., Morris J. C., Fagan A. M., Holtzman D. M., Goate A. M., SNPs associated with cerebrospinal fluid Phospho-tau levels influence rate of decline in alzheimer's disease. PLoS Genetics 2010 6 9 2-s2.0-78049448191 10.1371/journal.pgen.1001101 e1001101
150. Alexopoulos P., Guo L.-H., Kratzer M., Westerteicher C., Kurz A., Perneczky R., Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers Alzheimer's Disease Neuroimaging Initiative. Dementia and Geriatric Cognitive Disorders 2011 32 3 164 170 2-s2.0-80053906759 10.1159/000332017
151. Kauwe J. S. K., Cruchaga C., Karch C. M., Sadler B., Lee M., Mayo K., Latu W., Su'a M., Fagan A. M., Holtzman D. M., Morris J. C., Goate A. M., Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease. PLoS ONE 2011 6 2 2-s2.0-79951798741 10.1371/journal.pone.0015918 e15918
152. Schjeide B.-M. M., Schnack C., Lambert J.-C., Lill C. M., Kirchheiner J., Tumani H., Otto M., Tanzi R. E., Lehrach H., Amouyel P., Von Arnim C. A. F., Bertram L., The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels. Archives of General Psychiatry 2011 68 2 207 213 2-s2.0-79951499355 10.1001/archgenpsychiatry.2010.196
153. Lee S. H., Harold D., Nyholt D. R., Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis. Human Molecular Genetics 2013 22 832 841
154. Moore J. H., The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Human Heredity 2003 56 1-3 73 82 2-s2.0-0345411335 10.1159/000073735 (Pubitemid 37465073)
155. Moore J. H., Williams S. M., Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis. BioEssays 2005 27 6 637 646 2-s2.0-21244459227 10.1002/bies.20236 (Pubitemid 40896095)
156. Moore J. H., Williams S. M., Epistasis and its implications for personal genetics. American Journal of Human Genetics 2009 85 3 309 320 2-s2.0-69449103972 10.1016/j.ajhg.2009.08.006
157. Cordell H. J., Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Human Molecular Genetics 2002 11 20 2463 2468 2-s2.0-0036797562 (Pubitemid 35174710)
158. Culverhouse R., Suarez B. K., Lin J., Reich T., A perspective on epistasis: limits of models displaying no main effect. American Journal of Human Genetics 2002 70 2 461 471 2-s2.0-0036155238 10.1086/338759 (Pubitemid 34112299)
159. Carlborg Ö., Haley C. S., Epistasis: too often neglected in complex trait studies? Nature Reviews Genetics 2004 5 8 618 625 2-s2.0-3442894519 10.1038/nrg1407 (Pubitemid 39005756)
160. Thornton-Wells T. A., Moore J. H., Haines J. L., Genetics, statistics and human disease: analytical retooling for complexity. Trends in Genetics 2004 20 12 640 647 2-s2.0-7444257916 10.1016/j.tig.2004.09.007 (Pubitemid 39441283)
161. Phillips P. C., Epistasis-the essential role of gene interactions in the structure and evolution of genetic systems. Nature Reviews Genetics 2008 9 11 855 867 2-s2.0-54149088214 10.1038/nrg2452
162. Ritchie M. D., Hahn L. W., Roodi N., Bailey L. R., Dupont W. D., Parl F. F., Moore J. H., Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. American Journal of Human Genetics 2001 69 1 138 147 2-s2.0-0034973569 10.1086/321276 (Pubitemid 32614026)
163. Andrew A. S., Nelson H. H., Kelsey K. T., Moore J. H., Meng A. C., Casella D. P., Tosteson T. D., Schned A. R., Karagas M. R., Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 2006 27 5 1030 1037 2-s2.0-33646187199 10.1093/carcin/bgi284
164. Briollais L., Wang Y., Rajendram I., Onay V., Shi E., Knight J., Ozcelik H., Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario. BMC Medicine 2007 5, article 22 2-s2.0-34548782144 10.1186/1741-7015-5-22 (Pubitemid 47423380)
165. Chen M., Kamat A. M., Huang M., Grossman H. B., Dinney C. P., Lerner S. P., Wu X., Gu J., High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis 2007 28 10 2160 2165 2-s2.0-35148822240 10.1093/carcin/bgm167 (Pubitemid 47543377)
166. Tsai C.-T., Hwang J.-J., Ritchie M. D., Moore J. H., Chiang F.-T., Lai L.-P., Hsu K.-L., Tseng C.-D., Lin J.-L., Tseng Y.-Z., Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis 2007 195 1 172 180 2-s2.0-35248854946 10.1016/j.atherosclerosis.2006.09.014 (Pubitemid 47561934)
167. Chan I. H. S., Leung T. F., Tang N. L. S., Li C. Y., Sung Y. M., Wong G. W. K., Wong C. K., Lam C. W. K., Gene-gene interactions for asthma and plasma total IgE concentration in Chinese children. Journal of Allergy and Clinical Immunology 2006 117 1 127 133 2-s2.0-29544436372 10.1016/j.jaci.2005.09.031 (Pubitemid 43017149)
168. Lee J.-Y., Kwon J.-C., Kim J.-J., Multifactor dimensionality reduction (MDR) analysis to detect single nucleotide polymorphisms associated with a carcass trait in a Hanwoo population. Asian-Australasian Journal of Animal Sciences 2008 21 6 784 788 2-s2.0-44449174546 (Pubitemid 351762183)
169. Ritchie M. D., Haas D. W., Motsinger A. A., Donahue J. P., Erdem H., Raffanti S., Rebeiro P., George A. L., Kim R. B., Haines J. L., Sterling T. R., Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity. Clinical Infectious Diseases 2006 43 6 779 782 2-s2.0-33748288115 10.1086/507101 (Pubitemid 44330745)
170. Park H.-W., Shin E.-S., Lee J.-E., Kwon H.-S., Chun E., Kim S.-S., Chang Y.-S., Kim Y.-K., Min K.-U., Kim Y.-Y., Cho S.-H., Multilocus analysis of atopy in Korean children using multifactor- dimensionality reduction. Thorax 2007 62 3 265 269 2-s2.0-33947586216 10.1136/thx.2006.065482 (Pubitemid 46579811)
171. Manuguerra M., Matullo G., Veglia F., Autrup H., Dunning A. M., Garte S., Gormally E., Malaveille C., Guarrera S., Polidoro S., Saletta F., Peluso M., Airoldi L., Overvad K., Raaschou-Nielsen O., Clavel-Chapelon F., Linseisen J., Boeing H., Trichopoulos D., Kalandidi A., Palli D., Krogh V., Tumino R., Panico S., Bueno-De-Mesquita H. B., Peeters P. H., Lund E., Pera G., Martinez C., Amiano P., Barricarte A., Tormo M. J., Quiros J. R., Berglund G., Janzon L., Jarvholm B., Day N. E., Allen N. E., Saracci R., Kaaks R., Ferrari P., Riboli E., Vineis P., Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. Carcinogenesis 2006 28 2 414 422 2-s2.0-33847270241 10.1093/carcin/bgl159 (Pubitemid 46321858)
172. Julià A., Moore J., Miquel L., Alegre C., Barceló P., Ritchie M., Marsal S., Identification of a two-loci epistatic interaction associated with susceptibility to rheumatoid arthritis through reverse engineering and multifactor dimensionality reduction. Genomics 2007 90 1 6 13 2-s2.0-34250006823 10.1016/j.ygeno.2007.03.011 (Pubitemid 46891734)
173. Edwards T. L., Lewis K., Velez D. R., Dudek S., Ritchie M. D., Exploring the performance of multifactor dimensionality reduction in large scale SNP studies and in the presence of genetic heterogeneity among epistatic disease models. Human Heredity 2009 67 3 183 192 2-s2.0-57449101697 10.1159/000181157
174. Cho Y. M., Ritchie M. D., Moore J. H., Park J. Y., Lee K.-U., Shin H. D., Lee H. K., Park K. S., Multifactor-dimensionality reduction shows a two-locus interaction associated with type 2 diabetes mellitus. Diabetologia 2004 47 3 549 554 2-s2.0-1842866369 10.1007/s00125-003-1321-3 (Pubitemid 38491253)
175. Robson K. J. H., Lehmann D. J., Wimhurst V. L. C., Livesey K. J., Combrinck M., Merryweather-Clarke A. T., Warden D. R., Smith A. D., Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease. Journal of Medical Genetics 2004 41 4 261 265 2-s2.0-1942469548 (Pubitemid 38496768)
176. Muendlein A., Saely C. H., Marte T., Schmid F., Koch L., Rein P., Langer P., Aczel S., Drexel H., Synergistic effects of the apolipoprotein E ε 3/ ε 2/ ε 4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C > T polymorphisms on their association with coronary artery disease. Atherosclerosis 2008 199 1 179 186 2-s2.0-46149104137 10.1016/j.atherosclerosis.2007.10.030
177. Polito L., Kehoe P. G., Davin A., The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts. Alzheimer's & Dementia 2013 9 4 392 399
178. Hiltunen M., Mannermaa A., Helisalmi S., Koivisto A., Lehtovirta M., Ryynänen M., Riekkinen P. Sr., Soininen H., Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients. Neuroscience Letters 1998 250 1 69 71 2-s2.0-0032568899 10.1016/S0304-3940(98)00453-4 (Pubitemid 28341779)
179. Licastro F., Chiappelli M., Grimaldi L. M. E., Morgan K., Kalsheker N., Calabrese E., Ritchie A., Porcellini E., Salani G., Franceschi M., Canal N., A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease. Neurobiology of Aging 2005 26 4 449 453 2-s2.0-19944429724 10.1016/j.neurobiolaging.2004.05.001 (Pubitemid 40093928)
180. Talbot C., Houlden H., Craddock N., Crook R., Hutton M., Lendon C., Prihar G., Morris J. C., Hardy J., Goate A., Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. NeuroReport 1996 7 2 534 536 2-s2.0-0029867041 (Pubitemid 26105035)
181. Combarros O., García-Román M., Fontalba A., Fernández-Luna J. L., Llorca J., Infante J., Berciano J., Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2003 15 3 151 154 2-s2.0-12244274984 10.1159/000068480 (Pubitemid 36206644)
182. Kamino K., Nagasaka K., Imagawa M., Yamamoto H., Yoneda H., Ueki A., Kitamura S., Namekata K., Miki T., Ohta S., Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochemical and Biophysical Research Communications 2000 273 1 192 196 2-s2.0-0034709574 10.1006/bbrc.2000.2923 (Pubitemid 30426885)
183. Kim J.-M., Stewart R., Shin I.-S., Jung J.-S., Yoon J.-S., Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer's disease in an older Korean population. Neurobiology of Aging 2004 25 3 295 301 2-s2.0-1242293691 10.1016/S0197-4580(03)00114-3 (Pubitemid 38220964)
184. Combarros O., van Duijn C. M., Hammond N., Belbin O., Arias-Vásquez A., Cortina-Borja M., Lehmann M. G., Aulchenko Y. S., Schuur M., Kölsch H., Heun R., Wilcock G. K., Brown K., Kehoe P. G., Harrison R., Coto E., Alvarez V., Deloukas P., Mateo I., Gwilliam R., Morgan K., Warden D. R., Smith A. D., Lehmann D. J., Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease. Journal of Neuroinflammation 2009 6, article 22 2-s2.0-71049194220 10.1186/1742-2094-6-22
185. Bullock J. M., Medway C., Cortina-Borja M., Discovery by the Epistasis project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease. Neurobiology of Aging 2013 34 4 1309.e1 1309.e7
186. Rodríguez-Rodríguez E., Mateo I., Infante J., Llorca J., García-Gorostiaga I., Vázquez-Higuera J. L., Sánchez-Juan P., Berciano J., Combarros O., Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk. Brain Research 2009 1280 166 171 2-s2.0-67649649934 10.1016/j.brainres.2009.05.019
187. Kauwe J. S. K., Bertelsen S., Mayo K., Cruchaga C., Abraham R., Hollingworth P., Harold D., Owen M. J., Williams J., Lovestone S., Morris J. C., Goate A. M., Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. American Journal of Medical Genetics B 2010 153 4 955 959 2-s2.0-77952685777 10.1002/ajmg.b.31053
188. Combarros O., Cortina-Borja M., Smith A. D., Lehmann D. J., Epistasis in sporadic Alzheimer's disease. Neurobiology of Aging 2009 30 9 1333 1349 2-s2.0-67650470272 10.1016/j.neurobiolaging.2007.11.027
189. Cortina-Borja M., Smith A. D., Combarros O., Lehmann D. J., The synergy factor: a statistic to measure interactions in complex diseases. BMC Research Notes 2009 2, article 105 2-s2.0-71049187007 10.1186/1756-0500-2-105
190. Ritchie M. D., Hahn L. W., Moore J. H., Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genetic Epidemiology 2003 24 2 150 157 2-s2.0-0037310257 10.1002/gepi.10218 (Pubitemid 36158211)
191. Hahn L. W., Ritchie M. D., Moore J. H., Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003 19 3 376 382 2-s2.0-0037433052 10.1093/bioinformatics/btf869 (Pubitemid 36284937)
192. Coffey C. S., Hebert P. R., Ritchie M. D., Krumholz H. M., Gaziano J. M., Ridker P. M., Brown N. J., Vaughan D. E., Moore J. H., An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation. BMC Bioinformatics 2004 5, article 49 2-s2.0-2942517830 10.1186/1471-2105-5-49 (Pubitemid 38751287)
193. Infante J., Sanz C., Fernández-Luna J. L., Llorca J., Berciano J., Combarros O., Gene-gene interaction between interleukin-6 and interleukin-10 reduces AD risk. Neurology 2004 63 6 1135 1136 2-s2.0-4644319999 (Pubitemid 39287939)
194. Robson K. J. H., Lehmann D. J., Wimhurst V. L. C., Livesey K. J., Combrinck M., Merryweather-Clarke A. T., Warden D. R., Smith A. D., Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease. Journal of Medical Genetics 2004 41 4 261 265 2-s2.0-1942469548 (Pubitemid 38496768)